Prevention of Mortality and Pneumonia Among Nursing Home Older Adults by Dual Pneumococcal and Seasonal Influenza Vaccination During a Pandemic Caused by Novel Pandemic Influenza A (H1N1)

Journal of the American Medical Directors Association

Volumn 13, Issue 8, 2012, Pages 698-703

  Chan, Tuen Ching ^a,b   Hung, Ivan Fan Ngai ^b   Luk, James Ka Hay ^a   Shea, Yat Fung ^a,b   Chan, Felix Hon Wai ^a   Woo, Patrick Chiu Yat ^b   Chu, Leung Wing ^b  

^a Fung Yiu King Hospital   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Efficacy; Influenza; Nursing home older adults; Pandemic influenza A H1N1; Pneumococcus; Vaccination

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; HONG KONG; HUMAN; ICD-9-CM; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NURSING HOME; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIA; VACCINATION;

EID: 84866755851     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2012.05.009     Document Type: Article

References (51)

1. Center of Health Protection (CHP). The Government of the Hong Kong Special Administrative Region. Vital statistics. Number of death by leading cause of death 2001-2011. Available at: Accessed February 28, 2012. http://www.chp.gov.hk/.
2. Janssens J.P., Krause K.H. Pneumonia in the very old. Lancet Infect Dis 2004, 4:112-124.
3. Lim W.S., Macfarlane J.T. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001, 18:362-368.
4. Maruyama T., Niederman M.S., Kobayashi T., et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med 2008, 102:1287-1295.
5. Simell B., Vuorela A., Ekstrom N., et al. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine 2011, 29:1929-1934.
6. Romero-Steiner S., Musher D.M., Cetron M.S. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 1999, 29:281-288.
7. Hung F.N., Leung Y.M., Chu W.S., et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: A prospective cohort study. Clin Infect Dis 2010, 51:1007-1016.
8. Luey K.Y., Kam K.M. Vaccine coverage of Streptococcus pneumoniae in Hong Kong with attention to the multiple antibiotic resistant strains. Vaccine 1996, 14:1573-1580.
9. You J.H.S., Wong W.C.W., Ip M., et al. Cost effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities. J Epidemiol Community Health 2009, 63:906-911.
10. Wu J.T., Ma E.S.K., Lee C.K., et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010, 51:1184-1191.
11. Chan T.C., Hung I.F., Luk J.K., et al. Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: A one-year prospective cohort study. Vaccine 2011, 29:7773-7778.
12. Lau J.T., Yeung N.C., Choi K.C., et al. Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: Population based cross sectional survey. BMJ 2009, 339:b4164.
13. Chor J.S., Ngai K.L., Goggins W.B., et al. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: Two questionnaire surveys. BMJ 2009, 339:b3391.
14. Hospital Authority annual report 2009-2010. Available at: Accessed February 28, 2011. http://www.ha.org.hk/.
15. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987, 40:373-383.
16. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative database. J Clin Epidemiol 1992, 45:613-619.
17. Groot V., Beckerman H., Lankhorst G.J., et al. How to measure comorbidity: A critical review of available methods. J Clin Epidemiol 2003, 56:221-229.
18. Schneeweiss S., Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000, 29:891-898.
19. Mahoney F., Barthel D. Functional evaluation: The Barthel Index. Md Med J 1965, 14:61-65.
20. Torres O., Munoz J., Ruiz D., et al. Outcome predictors of pneumonia in elderly patients: Importance of functional assessment. J Am Geriatr Soc 2004, 52:1603-1609.
21. Lunney J.R., Lynn J., Foley D.J., et al. Patterns of functional decline at the end of life. JAMA 2003, 289:2387-2392.
22. Covinsky K.E., Palmer R.M., Fortinsky R.H., et al. Loss of independence in activities of daily living in older adults hospitalised with medical illnesses: Increased vulnerability with age. J Am Geriatr Soc 2003, 51:451-458.
23. Maruyama T., Taguchi O., Niederman M.S., et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: Double blind, randomized and placebo controlled trial. BMJ 2010, 340:c1004.
24. Christenson B., Hedlund J., Lundbergh P., Ortqvist A. Additive prevention effective of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004, 23:363-368.
25. Ridda I., MacIntyre C.R., Lindley R., et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 2009, 27:1628-1636.
26. Kawakami K., Ohkusa Y., Kuroki R., et al. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine 2010, 28:7063-7069.
27. Ortqvist A., Hedlund J., Burman L.A., et al. Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet 1998, 351:399-403.
28. Huss A., Scott P., Stuck A., et al. Efficacy of pneumococcal vaccination in adults: A meta-analysis. CMAJ 2009, 180:48-58.
29. Johnstone J., Eurich D.T., Minhas J.K., et al. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Clin Infect Dis 2010, 51:15-22.
30. Schembri S., Morant S., Winter J.H., MacDonald T.M. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 2009, 64:567-572.
31. Liang X.F., Wang X.Q., Wang J.Z., et al. Safety and immunogenicity of pandemic influenza A vaccine in China: A multi-centre, double blind, randomized, placebo controlled trial. Lancet 2010, 375:56-66.
32. Smith K.J., Zimmerman R.K., Nowalk M.P., et al. Age, revaccination, and tolerance effects on pneumococcal vaccination strategies in the elderly: A cost effectiveness analysis. Vaccine 2009, 27:3159-3164.
33. Ridda I., MacIntyre C.R., Lindley R., et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 2009, 27:1628-1636.
34. Hammitt L.L., Bulkow L.R., Singleton R.J., et al. Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: No evidence of hyporesponsiveness. Vaccine 2011, 29:2287-2295.
35. Manoff S.B., Liss C., Caulfield M.J., et al. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged more than 65 years. J Infect Dis 2010, 201:525-533.
36. Goldblatt D., Southern J., Andrews N., et al. The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years. Clin Infect Dis 2009, 49:1318-1325.
37. Simansen L., Taylor R.J., Viboud C., et al. Mortality benefits of influenza vaccination in elderly people: An ongoing controversy. Lancet Infect Dis 2007, 7:658-666.
38. Nelson J., Jackson M., Weiss N., Jackson L. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 2009, 62:687-694.
39. Chan Carusone S.B., Walter S.D., Brazil K., Loeb M.B. Pneumonia and lower respiratory infections in nursing home residents: Predictors of hospitalization and mortality. J Am Geriatr Soc 2007, 55:414-419.
40. Loeb M., McGeer A., McArthur M., et al. Risk factors for pneumonia and other lower respiratory infections in elderly residents of long-term care facilities. Arch Intern Med 1999, 159:2058-2064.
41. Jackson L.A., Nelson J.C., Benson P., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006, 35:345-352.
42. Walston J., Ferrucci L. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006, 54:991.
43. Smeeth L., Thomas S.L., Hall A.J., et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004, 351:2611-2618.
44. Musher D.M., Rueda A.M., Kaka A.S., Mapara S.M. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007, 45:158-165.
45. Siriwardena A.N., Gwini S.M., Coupland C.A. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: Matched case-control study. CMAJ 2010, 182:1617-1623.
46. Binder C.J., Hörkkö S., et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: Molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003, 9:736-743.
47. Lamontagne F., Garant M.P., Carvalho J.C., et al. Pneumococcal vaccination and risk of myocardial infarction. CMAJ 2008, 179:773-777.
48. Lok K., Woo J., Hui E., et al. Usefulness of the Chinese Nutrition Screening (CNS) tool in predicting 12 month mortality in elderly Hong Kong Chinese living in institutions. J Nutr Health Aging 2009, 13:96-101.
49. Lee S.W., Chau P.H., Hui E., et al. Survival prediction in nursing home residents using the minimal data set subscales: ADL self-performance hierarchy, cognitive performance and changes in health, end stage diseases and symptoms and signs scales. Eur J Public Health 2009, 19:308-312.
50. Ma H.M., Tang W.H., Woo J. Predictors of in-hospital mortality of older patients admitted for community-acquired pneumonia. Age Ageing 2011, 40:736-741.
51. Chan W.K., Wong Y.Y., Yam H.K., et al. Risk factors of hospitalization and readmission of patients with COPD in Hong Kong population: Analysis of hospital admission records. BMC Health Serv Res 2011, 11:186-191.